Ligand ID: 95E Drugbank ID: DB00330(Ethambutol) Indication:For use, as an adjunct, in the treatment of pulmonary tuberculosis. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 5NR3_A_95EA401_0 (DNA(CYTOSINE-5)-METHYLTRANSFERASE 3B) | 6w4h | NSP16 (SARS-CoV-2) | 4 / 7 | ILE A6951PHE A6947ASP A6928LYS A6968 | 1.78A | 17.43 | NoneACT A7104 (-3.8A)SAM A7102 (-3.7A)ACT A7103 ( 4.0A) | ||
![]() | 5NR3_A_95EA401_0 (DNA(CYTOSINE-5)-METHYLTRANSFERASE 3B) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 7 | ILE C6951PHE C6947ASP C6928LYS C6968 | 1.80A | 23.26 | NoneFMT C7115 ( 3.5A)SAM C7105 ( 3.7A)FMT C7108 ( 3.9A) | ||
![]() | 5NR3_A_95EA401_0 (DNA(CYTOSINE-5)-METHYLTRANSFERASE 3B) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | ILE E 18ASP E 162LYS E 158SER C 5 | 1.63A | 19.78 | None | ||
![]() | 5NR3_A_95EA401_0 (DNA(CYTOSINE-5)-METHYLTRANSFERASE 3B) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | ILE E 18ASP E 162LYS E 158SER C 5 | 1.50A | 19.78 | None | ||
![]() | 5NR3_A_95EA401_0 (DNA(CYTOSINE-5)-METHYLTRANSFERASE 3B) | 7btf | NSP12 (SARS-CoV-2) | 4 / 7 | TRP A 162ASP A 161LYS A 160SER A 795 | 1.77A | 9.65 | None |